T. Rowe Price Associates’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

T. Rowe Price Associates’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-939,425	Closed	-$94.6M	–	2617
2014 Q4	$94.6M	Sell	939,425 -1,489,859	-61%	-$116M	0.02%	636
2014 Q3	$161M	Buy	2,429,284 +137,841	+6%	+$9.05M	0.04%	476
2014 Q2	$160M	Sell	2,291,443 -41,985	-2%	-$2.86M	0.03%	499
2014 Q1	$171M	Sell	2,333,428 -158,132	-6%	-$11.8M	0.04%	475
2013 Q4	$172M	Sell	2,491,560 -1,179,970	-32%	-$76.4M	0.04%	467
2013 Q3	$233M	Sell	3,671,530 -675,529	-16%	-$40.8M	0.06%	369
2013 Q2	$210M	Buy	+4,347,059	New	+$214M	0.06%	377

T. Rowe Price Associates's CBST Position: Q1 2015 in Review

T. Rowe Price Associates sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 939,425 shares — an estimated $94.6M sold.

T. Rowe Price Associates first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $233M in Q3 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

T. Rowe Price Associates reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
T. Rowe Price Associates sold 939,425 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $94.6M.
T. Rowe Price Associates first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
T. Rowe Price Associates's CUBIST PHARMACEUTICALS INC position peaked at $233M in Q3 2013.
0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.